T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Arq
ARQ
$102M
| $121K | ﹤0.01% |
16,868
+1,175
| +7% | +$7.76K |
|
2877
Paysign
PAYS
$729M
| $120K | ﹤0.01% |
18,928
| – | – |
|
2878
Fennec Pharmaceuticals
FENC
$424M
| $118K | ﹤0.01% |
12,504
+1,284
| +11% | +$11.1K |
|
2879
Inspired Entertainment
INSE
$163M
| $118K | ﹤0.01% |
12,514
+1,056
| +9% | +$9.53K |
|
2880
Puma Biotechnology
PBYI
$455M
| $115K | ﹤0.01% |
21,625
+2,059
| +11% | +$8.73K |
|
|
LPRO
2881
DELISTED
Open Lending Corp
LPRO
| $114K | ﹤0.01% |
53,882
+1,063
| +2% | +$2.4K |
|
2882
Satellogic
SATL
$890M
| $114K | ﹤0.01% |
34,579
| – | – |
|
|
ALMS
2883
Alumis Inc
ALMS
$3.21B
| $113K | ﹤0.01% |
28,274
| – | – |
|
|
SCPH
2884
DELISTED
scPharmaceuticals
SCPH
| $111K | ﹤0.01% |
19,431
| – | – |
|
2885
Palladyne AI
PDYN
$312M
| $111K | ﹤0.01% |
12,810
| – | – |
|
2886
Getty Images
GETY
$132M
| $110K | ﹤0.01% |
55,158
+7,178
| +15% | +$13.3K |
|
2887
Humacyte
HUMA
$160M
| $110K | ﹤0.01% |
62,842
| – | – |
|
2888
Tredegar Corp
TG
$276M
| $110K | ﹤0.01% |
13,598
+610
| +5% | +$5.03K |
|
2889
Codexis
CDXS
$178M
| $109K | ﹤0.01% |
44,269
+3,772
| +9% | +$10.3K |
|
2890
Virgin Galactic
SPCE
$462M
| $109K | ﹤0.01% |
28,140
+14,600
| +108% | +$48.9K |
|
2891
Xponential Fitness
XPOF
$211M
| $109K | ﹤0.01% |
13,959
+1,780
| +15% | +$16.2K |
|
2892
Ironwood Pharmaceuticals
IRWD
$687M
| $106K | ﹤0.01% |
80,178
-92,343
| -54% | -$95.6K |
|
2893
Sky Harbour Group
SKYH
$368M
| $106K | ﹤0.01% |
10,684
| – | – |
|
2894
Radiant Logistics
RLGT
$406M
| $105K | ﹤0.01% |
17,780
| – | – |
|
|
KLC
2895
KinderCare Learning Companies
KLC
$581M
| $105K | ﹤0.01% |
15,803
| – | – |
|
|
STLN
2896
Starling Oncology, Inc. Common Stock
STLN
$644M
| $104K | ﹤0.01% |
29,764
| – | – |
|
2897
Perspective Therapeutics
CATX
$364M
| $103K | ﹤0.01% |
29,769
+978
| +3% | +$3.56K |
|
2898
Lifezone Metals
LZM
$343M
| $103K | ﹤0.01% |
18,726
| – | – |
|
2899
Mistras Group
MG
$570M
| $103K | ﹤0.01% |
10,437
| – | – |
|
2900
Intellicheck
IDN
$74.7M
| $102K | ﹤0.01% |
19,500
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.